Siddavaram Nagini
Overview
Explore the profile of Siddavaram Nagini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bishayee A, Penn A, Bhandari N, Petrovich R, DeLiberto L, Burcher J, et al.
Phytother Res
. 2024 Aug;
38(11):5225-5263.
PMID: 39193857
Oral cancer is a disease with high mortality and rising incidence worldwide. Although fragmentary literature on the anti-oral cancer effects of plant products has been published, a comprehensive analysis is...
2.
Nagini S, Kallamadi P, Tanagala K, Reddy G
Oncol Res
. 2024 Jul;
32(8):1287-1308.
PMID: 39055885
Aldo-keto reductases (AKRs) are a superfamily of enzymes that play crucial roles in various cellular processes, including the metabolism of xenobiotics, steroids, and carbohydrates. A growing body of evidence has...
3.
4.
Arvindh S, Priyadarshini M, Baba A, Veeravarmal V, Mishra R, Dash R, et al.
Curr Pharm Biotechnol
. 2024 Apr;
PMID: 38561609
Background: Deregulated DNA damage response (DDR) network is implicated in cancer progression and therapy resistance. Objective: The present study was designed to investigate whether nimbolide, an anticancer neem limonoid, targets...
5.
Jha A, Alam M, Kashyap T, Nath N, Kumari A, Pramanik K, et al.
Int Immunopharmacol
. 2023 Sep;
124(Pt A):110894.
PMID: 37678027
Background: Programmed cell death ligand-1 (PD-L1)is an antitumor immunity molecule and a great target to cure oral cancer; nonetheless, the limited success can be attributed to many complex pathways and...
6.
Nagini S, Palrasu M, Bishayee A
Med Res Rev
. 2023 Aug;
44(2):457-496.
PMID: 37589457
Neem (Azadirachta indica A. Juss.), a versatile evergreen tree recognized for its ethnopharmacological value, is a rich source of limonoids of the triterpenoid class, endowed with potent medicinal properties. Extracts...
7.
Kallamadi P, Esari D, Addi U, Kesavan R, Putcha U, Nagini S, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511200
Patients with comorbidities of obesity and diabetes are recognized to be at high risk of breast cancer development and face worse breast cancer outcomes. Though several reports showed the reinforced...
8.
Raju G, Bhat P, Nagini S
J Lab Physicians
. 2023 Jun;
15(2):237-242.
PMID: 37323608
The current study was undertaken to investigate the utility of total prostate-specific antigen (tPSA), its isoform [-2] proPSA (p2PSA), and prostate health index (PHI) in the diagnosis of metastatic prostate...
9.
Kumari A, Jha A, Tiwari A, Nath N, Kumar A, Nagini S, et al.
Arch Oral Biol
. 2023 Mar;
150:105688.
PMID: 36989865
Objective: This study aimed to determine whether glucose transporter-1/3 (GLUT1/3) increased expression could contribute to oral tumor severity. Furthermore, this study detected whether GLUT1/3 mRNA/protein was associated with oncogenic transcription...
10.
Nivetha R, Arvindh S, Baba A, Gade D, Gopal G, K C, et al.
Anticancer Agents Med Chem
. 2022 Feb;
22(14):2619-2636.
PMID: 35125086
Background & Objective: The insulin/IGF-1R/PI3K/Akt signalling cascade is increasingly being linked to breast cancer development, with aldose reductase (AR) playing a key role in mediating the crosstalk between this pathway...